ForteBio Lands $25M in Series C Financing

Sep 25, 2008

NEW YORK (GenomeWeb News) – ForteBio has reeled in $25 million in venture capital financing from existing and new investors, the Menlo Park, Calif.-based company said this week.

The Series C financing was led by new investor OrbiMed Advisors, and included investments from another new investor MPM Capital, and existing investors Alloy Ventures, Latterell Venture Partners, the Vertical Group, and Versant Ventures.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Breakthrough Prize Winners Announced

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

Misuse of Genetic Research

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Not Quite the Ivy League Gene

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

This Week in Nature

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.

Main menu